key: cord-0924480-77o8tjyf
authors: Fattahi, Zohreh; Mohseni, Marzieh; Jalalvand, Khadijeh; Aghakhani Moghadam, Fatemeh; Ghaziasadi, Azam; Keshavarzi, Fatemeh; Yavarian, Jila; Jafarpour, Ali; Mortazavi, Seyedeh Elham; Ghodratpour, Fatemeh; Behravan, Hanieh; Khazeni, Mohammad; Momeni, Seyed Amir; Jahanzad, Issa; Moradi, Abdolvahab; Tabarraei, Alijan; Azimi, Sadegh Ali; Kord, Ebrahim; Hashemi‐Shahri, Seyed Mohammad; Azaran, Azarakhsh; Yousefi, Farid; Mokhames, Zakiye; Soleimani, Alireza; Ghafari, Shokouh; Ziaee, Masood; Habibzadeh, Shahram; Jeddi, Farhad; Hadadi, Azar; Abdollahi, Alireza; Kaydani, Gholam Abbas; Soltani, Saber; Mokhtari‐Azad, Talat; Najafipour, Reza; Malekzadeh, Reza; Kahrizi, Kimia; Jazayeri, Seyed Mohammad; Najmabadi, Hossein
title: SARS‐CoV‐2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions
date: 2021-05-22
journal: Transbound Emerg Dis
DOI: 10.1111/tbed.14104
sha: 6df8828cb04b209f79f64927c0161715a8163c62
doc_id: 924480
cord_uid: 77o8tjyf

The SARS‐CoV‐2 virus has been rapidly spreading globally since December 2019, triggering a pandemic, soon after its emergence. While Iran was among the first countries confronted with rapid spread of virus in February 2020, no real‐time SARS‐CoV‐2 whole‐genome tracking in early phase of outbreak was performed in the country. To address this issue, we provided 50 whole‐genome sequences of viral isolates ascertained from different geographical locations in Iran during March–July 2020. The corresponding analysis on origins, transmission dynamics and genetic diversity of SARS‐CoV‐2 virus, represented at least two introductions of the virus into the country, constructing two major clusters defined as B.4 and B.1*. The first entry of the virus might have occurred around very late 2019/early 2020, as suggested by the time to the most recent common ancestor, followed by a rapid community transmission that led to dominancy of B.4 lineage in early epidemic till the end of June. Gradually, reduction in dominancy of B.4 occurred possibly as a result of other entries of the virus, followed by surge of B.1* lineages, as of mid‐May. Remarkably, variation tracking of the virus indicated the increase in frequency of D614G mutation, along with B.1* lineages, which showed continuity till October 2020. The increase in frequency of D614G mutation and B.1* lineages from mid‐May onwards predicts a rapid viral transmission that may push the country into a critical health situation followed by a considerable change in composition of viral lineages circulating in the country.

The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 (Zhu et al., 2020) has, as of 23 October 2020, exceeded one million deaths, while infecting 42,334,976 people worldwide.

Real-time whole-genome sequencing of this emerging virus was commenced at the early phase of outbreak globally, as it can accurately evaluate the magnitude of transmission, offering insights for management of the epidemic (Oude Munnink et al., 2020) .

Therefore, an increasing number of sequences are being deposited in the global initiative on sharing all influenza data (GISAID) (Shu & McCauley, 2017) .

Iran was among the first countries confronting the rapid virus spread. The first COVID-19 confirmed patient and death was reported on 19 February 2020, from Qom city. Local transmission to neighbouring provinces was reported just a day after and then the disease spread shortly Iran wide. The first outbreak peak dropped in April, but soon after relaxing the lockdown, the country experienced another notable increase in SARS-CoV-2 cases in May, which is still sustained. As of 23 October, 556,891 infected cases and 31,985 deaths have been reported officially and there is a concern about the increase in mortality rate in autumn and winter (https://www. world omete rs.info/coron aviru s/count ry/iran/).

with Italy and South Korea, no real-time SARS-CoV-2 whole-genome tracking was performed in the first months of epidemic. The first virus sequence from Iran was deposited in GISAID (EPI_ISL_424349) on April 4. In the same month, the study by Eden et al. revealed three major substitutions of G1397A, T28688C and G29742T in genomes of patients with travel history to Iran, which constitute a distinct clade representative of the specific viral diversity present in Iran at that time (Eden et al., 2020) .

As of 23 October 2020, there were only eight complete genomes available in GISAID, not sufficient for tracking the virus in the country, and the only epidemiologic study of Iranian outbreak used the genomic sequences ascertained from travellers to Iran, which estimated 21/01/2020 (95% HPD: 05/12/2019-14/02/2020) as the start of epidemic in Iran with a doubling time of 3 days (95% HPD: 1.68-16.27) (Ghafari et al., 2020) . To address this issue, we performed genome sequencing of 50 SARS-CoV-2 samples ascertained from different geographical locations and especially in early time intervals of the epidemic in Iran. We aimed at improving the understanding of the origins and transmission dynamics, circulating lineages and variation tracking of SARS-CoV-2 outbreak at early phase of Iranian epidemic, using molecular and phylogenetic methods. 

The SARS-CoV-2 virus has been rapidly spreading globally since December 2019, triggering a pandemic, soon after its emergence. While Iran was among the first countries confronted with rapid spread of virus in February 2020, no real-time SARS-CoV-2 whole-genome tracking in early phase of outbreak was performed in the country.

To address this issue, we provided 50 whole-genome sequences of viral isolates ascertained from different geographical locations in Iran during March-July 2020. The corresponding analysis on origins, transmission dynamics and genetic diversity of SARS-CoV-2 virus, represented at least two introductions of the virus into the country, constructing two major clusters defined as B.4 and B.1*. The first entry of the virus might have occurred around very late 2019/early 2020, as suggested by the time to the most recent common ancestor, followed by a rapid community transmission that led to dominancy of B.4 lineage in early epidemic till the end of June. Gradually, reduction in dominancy of B.4 occurred possibly as a result of other entries of the virus, followed by surge of B.1* lineages, as of mid-May. Remarkably, variation tracking of the virus indicated the increase in frequency of D614G mutation, along with B.1* lineages, which showed continuity till October 2020. The increase in frequency of D614G mutation and B.1* lineages from mid-May onwards predicts a rapid viral transmission that may push the country into a critical health situation followed by a considerable change in composition of viral lineages circulating in the country.

COVID-19, Iran, phylogenetic study, SARS-CoV-2, whole genome sequencing 2 | MATERIAL S AND ME THODS

We recruited 50 SARS-CoV-2 RNA samples, obtained as part of clinical testing in different referral centres of the following provinces: Alborz (n = 2), Ardabil (n = 4), Gilan (n = 6), Tehran (n = 27), Khuzestan (n = 3), Qom (n = 1), Sistan and Baluchestan (n = 3) and

South Khorasan (n = 4). All patients were referred between March and July 2020, with clinical presentations of COVID-19 disease, confirmed by real-time RT-PCR assay at those corresponding local centres.

Whole-genome sequencing of SARS-CoV-2 RNA samples was performed by targeted enrichment using CleanPlex® SARS-CoV-2

Research and Surveillance Panel (Paragon Genomics, Inc.). All samples were paired-end sequenced on Illumina MiSeq instrument using 300-cycle MiSeq v2 reagent kits (Illumina, Inc.), generating 5.4 Gb of data (94.5% of bases > = Q30). Initially, FASTQ files were assessed by FastQC (Andrews, 2010) and then pre-processed using Fastp (Chen et al., 2018) . The sequences were aligned to the SARS-CoV-2 reference genome (NC_045512.2) using Bowtie2 (Langmead & Salzberg, 2012) and keeping the reads mapped in proper pair. The resultant filtered BAM files were used for assembly of consensus SARS-CoV-2 sequences with Samtools mpileup and Bcftools (Li et al., 2009.) . Finally, the consensus FASTQ files were converted into FASTA format by Seqtk (https://github.com/lh3/seqtk), masking bases with quality lower than 20 to ambiguous nucleotides (N).

In addition to 50 sequenced samples in this project, eight other SARS-CoV-2 Iranian sequences from GISAID were subjected to lineage assignment. We applied Pangolin v2.0.7 , CoV-GLUE (Singer et al., 2020) and NextClade v.0.6.0 (Hadfield et al., 2018) to assign the global lineages present in Iranian SARS-CoV-2 outbreak.

BEAST v1.10.4 was used to construct a phylogenetic tree and to estimate the most recent common ancestor (TMRCA) (Drummond & Rambaut, 2007) . First, consensus sequences were evaluated by NextClade (Hadfield et al., 2018) , and sequences containing >5% ambiguous nucleotides and bearing private mutations above the threshold were excluded from downstream analysis. To explore the temporal signal, high-quality FASTA files were aligned by MAFFT v7.407 using the FFT-NS-2 algorithm (Katoh & Standley, 2013) , and then, a maximum-likelihood phylogenetic tree was built applying IQ-TREE v2.1.1 with GTR + gamma model (Minh et al., 2020) and temporal signal was then explored by TempEst (Rambaut et al., 2016) .

Eventually, BEAST was used to estimate TMRCA and construct a Bayesian phylogenetic tree of 45 sequences, plus Wuhan-1 patient (EPI_ISL_402125) as outgroup, using a simple model consisting of HKYγ codon partitioned 1 + 2, 3 substitution model, strict clock and coalescent exponential growth tree prior. Maximum clade credibility (MCC) tree was then made with 10% burn-in from two separate Markov chain-Monte Carlo runs (Drummond and Rambaut, 2007) .

To trace possible sources of SARS-CoV-2 entry into Iran, an additional phylogenetic tree was constructed based on a total of 261 samples including a list of high-quality genomes in GISAID (Rambaut, 2020) from the start of epidemic till the end of February, and random subsets of samples in GISAID during March-June interval, that were selected using mothur (Schloss et al., 2009 ).

Variant analysis was performed by CoV-GLUE, relative to the reference sequence (NC_045512.1) (Singer et al., 2020) . In total, 53 samples were investigated after excluding the sequences bearing private mutations above the threshold. Moreover, to track the renowned D614G mutation frequency after July 2020, sanger sequencing of additional 67 SARS-CoV2 positive samples collected during July-October, was performed using the following primer pairs designed by ARTIC network (https://github. com/artic -netwo rk/artic -ncov2 019/tree/maste r/primer_schem es/nCoV-2019/V3); 5ʹ-CCAGCAACTGTTTGTGGACCTA-3ʹ, 5ʹ

-CAGCCCCTATTAAACAGCCTGC-3ʹ.

In this study, we obtained 44 high-quality SARS-CoV-2 sequences (>98% of the genome is complete) from the Iranian outbreak. The remaining six samples covered >82% of the NC_045512.2 genome sequence. The metadata information including the geographical location, collection date, age, gender, CT value, specimen source, percentage of ambiguous nucleotides (N) for each genome, percentage of genome coverage compared to NC_045512.2 and the exact lineages defined for each sample are provided in Table S1 .

Lineage assignment with Pangolin and CoV-GLUE, although slightly different for some samples, both yielded B.4 as the dominant lineage circulating in Iranian SARS-CoV-2 outbreak; comprising 75.9% and 74%, respectively (see Figure 1a for spectrum of circulating lineages and Table S1 for exact lineage of each sample). This is consistent with previous reports (Eden et al., 2020) , as also the majority (83%) of SARS-CoV-2 sequences in GISAID that were primarily exposed in Iran, belonged to the B.4 lineage (Table   S2) (Eden et al., 2020) . This is now confirmed by locating five samples from these countries within the major Iranian cluster (EPI_ISL_412965, EPI_ISL_413213, EPI_ISL_412975, EPI_ISL_413214 and EPI_ISL_413490). All these five samples were collected in late February having a travel history to Iran ( Figure 3, Figure 4) . 

We detected 14 different variants with >10% frequency in SARS-CoV-2 genomes from Iranian outbreak (Table 1) . Notably, just four variants, namely G1397A, T28688C, G29742T and G11083T, con- 

Remarkably, we observed two specific haplotypes; the co- (Table 1) , not detected in sequences from SARS-CoV-2 pandemic (Mercatelli and Giorgi, 2020; Singer et al., 2020) . Although the exact variants were unique, different missense variants at the same location were identified in other viral sequences around the world. 

Spike is the key glycoprotein mediating entry of the virus to the cell and, therefore, the target of most vaccine strategies (Korber et al., 2020) . We thus focussed on variants located in spike protein of viral isolates from Iran and identified spike variants in 28 samples (53%), in which D614G and T22I were occurring at higher frequencies of 24.5% and 17%, respectively (Table 2) 

The current study is the first comprehensive analysis of SARS-CoV-2 full genomes obtained from Iranian outbreak. Regarding the importance of real-time sequencing of emerging viruses, and lack of full genomes from Iran, this study was designed to provide 50 SARS-CoV-2 full genome sequences of the early time interval of epidemic in Iran.

Lineage assignment and phylogenetic analysis of these sequences clarified the origins and transmission dynamics of SARS-CoV-2 outbreak in Iran, in which two major introductions into the country were detected, constructing two major clusters of the virus in different times, followed by rapid community transmission throughout the country.

These data confirm the B.4 as the dominant lineage in Iran, from the start of epidemic till the end of June. This lineage was primarily introduced as a prevalent distinct clade in Australian travellers from Iran in early April (Eden et al., 2020) . Since then, it is recognized as the Iranian epidemic. Nonetheless, no specific study on Iranian SARS-CoV-2 samples was performed so far, which is addressed in this study.

Furthermore, the B.4 clade TMRCA in this study along with the previous epidemiologic study that used genomic samples ascertained from travellers to Iran (Ghafari et al., 2020) In addition to outbreak tracing, these full genome sequences can provide beneficial information in understanding the genome diversity of viral isolates in Iran, helpful in adapting more specific diagnostic tests, therapeutic approaches and vaccines.

Generally, RNA viruses are known to have a high mutation rate, explained by lack of proofreading activity of RNA-dependent RNA polymerase (RdRp). However, coronaviruses are among the exceptions, with lower mutation rates due to presence of RdRpindependent proofreading activity (Ahmadpour et al., 2020; Peck and Lauring, 2018) . The mutation rate of 1.12 × 10 -3 mutations per site year (Koyama et al., 2020) and the average 7.23 mutations per sample (Mercatelli and Giorgi, 2020) were identified in low proportion of samples. Therefore, none of those could be considered as adapted geographically in Iranian SARS-CoV-2 samples. Indeed, massive sequencing of a larger cohort is a requisite for investigating the significance of these variants.

Moreover, the impact of these country-specific variants (yet to be defined) on the behaviour of virus (replication efficiency, virulence.

etc.) needs further investigation.

Despite the relatively low mutation rate of SARS-CoV-2, still a total of 353,341 mutations were identified in 48,635 SARS-CoV-2 genomes (Mercatelli and Giorgi, 2020) . Among these, studying the mutations in spike protein is necessary, as this immunogenic structural protein mediates the virus entry to the host cells via interacting with cellular receptors such as angiotensin-converting enzyme 2 (ACE2) and as it plays a key role in induction of neutralizing antibodies (Dearlove et al., 2020 ; Franco-Muñoz et al., 2020) . This glycoprotein is composed of two functional subunits, S1 and S2. S1 contains a receptor-binding domain (RBD) through which SARS-Co-2 binds to the ACE2 receptor, while S2 is responsible for virus-host membrane fusion (Yang et al., 2020) . Furthermore, the spike protein is the target for many vaccine candidates currently in development, and therefore, tracking the mutations in this protein (especially RBD region) is crucial (Dearlove et al., 2020 ) .

Monitoring the spike mutations in Iranian SARS-CoV-2 genomes revealed no novel mutations in this genomic region, while determined two commonly known mutations, T22I and D614G. Both of these variants are outside RBD region, suggesting no negative effect for efficacy of the future vaccines on the viral lineages currently circulating in Iran (Dearlove et al., 2020 ) .

While the T22I mutation is less frequent in other regions, the D614G variant is now the most prevalent mutation in COVID-19

pandemic (Ahmadpour et al., 2020; Korber et al., 2020; Mercatelli and Giorgi, 2020) . Recent studies suggested a fitness advantage for G614, rapidly making it the dominant form in each geographical location (Korber et al., 2020) . A significant conformational change in spike protein may lead to more feasible virus-host cell membrane fusion. As a consequence, increased infectivity, transmission and replication fitness is reported for G614 (Hu et al., 2020) , but there are still some debates about its transmission effect (Grubaugh et al., 2020 , van Dorp et al., 2020 . Hopefully, the mutation is not related to disease severity and does not reduce the effect of neutralizing antibodies (Korber et al., 2020; Fau et al., 2021.) .

Notably 

The authors have no conflict of interest to declare. 

Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic

FastQC: a quality control tool for high throughput sequence data

fastp: An ultra-fast all-in-one FASTQ preprocessor

A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants

BEAST: Bayesian evolutionary analysis by sampling trees

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran

Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America

Ongoing outbreak of COVID-19 in Iran: Challenges and signs of concern with under-reporting of prevalence and deaths: Research square

Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear

Nextstrain: Realtime tracking of pathogen evolution

The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera

Infectivity of SARS-CoV-2: There is something more than D614G?

MAFFT multiple sequence alignment software version 7: Improvements in performance and usability

Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus

Variant analysis of SARS-CoV-2 genomes

Fast gapped-read alignment with Bowtie 2

The Sequence alignment/map format and SAMtools

Geographic and Genomic Distribution of SARS-CoV-2 Mutations

IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era

Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands

Complexities of viral mutation rates

Spike mutation D614G alters SARS-CoV-2 fitness

Phylodynamic analysis | 176 genomes | 6

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen)

Introducing mothur: Opensource, platform-independent, community-supported software for describing and comparing microbial communities

GISAID: Global initiative on sharing all influenza data -from vision to reality

CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation

No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor